Novavax to Present at the 27th Annual Piper Jaffray Healthcare Conference

GAITHERSBURG, Md., Nov. 24, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that Stanley C. Erck, President and CEO, will present at the 27th Annual Piper Jaffray Healthcare Conference.

Conference details are as follows:

Date: Tuesday, December 1, 2015Time: 2:00 p.m. U.S. Eastern TimeLocation: New York Palace Hotel, New York CityLive webcast: http://edge.media-server.com/m/p/ui3ne8dn

The webcast and a replay of the presentation will also be accessible under the “Investors/Events” section of the Novavax website at novavax.com.

About Novavax

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. Additional information about Novavax is available on the Company’s website, novavax.com.

Contact:

Novavax, Inc.

Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer

Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations

[email protected]
240-268-2000

Russo Partners, LLC

David Schull
Todd Davenport, Ph.D.

[email protected]
[email protected]
212-845-4271

You May Also Be Interested In

• Industrial Vending Machine Market to Reach USD 6.4 Billion by 2031 Driven by Rising Demand for Efficiency and Growing Focus on Inventory Management
• TRIMEDX being recognized as a Top 100 at North American Inspiring Workplaces Awards
• Olmeca Altos® Tequila and Actress Busy Philipps Launch the Altos Tequila Emergency HotLime Just in Time for Margarita Season.